Cardiovascular and Thoracic Surgery Department, St Luc's Hospital, Catholic University of Louvain, Brussels, Belgium.
Cardiovascular and Thoracic Surgery Department, St Luc's Hospital, Catholic University of Louvain, Brussels, Belgium.
J Thorac Cardiovasc Surg. 2019 Jul;158(1):14-23. doi: 10.1016/j.jtcvs.2018.10.155. Epub 2018 Nov 26.
To analyze our long-term experience with valve-sparing reimplantation technique for the treatment of isolated root aneurysm, aneurysm with significant aortic regurgitation, and for isolated aortic regurgitation.
Between 1999 and 2017, 440 consecutive patients underwent valve-sparing reimplantation in our institution. The mean age of this cohort was 49 ± 15 years. Time-to-event analysis was performed with the Kaplan-Meier method, whereas significant predictors of late outcomes were explored with Cox proportional hazard model.
In-hospital mortality was 0.7% (n = 3). Four hundred fourteen patients were available for long-term analysis. Median duration of follow-up was 5 years (interquartile range, 2-8.5 years). Thirty-six patients (8.5%) died during follow-up; therefore, survival was 79.7% ± 3.8% at 10 years. During follow-up we observed a linearized rate of 0.37%, 0.73%, and 0.2% patient-year, respectively, for major bleeding, thromboembolic events, and infective endocarditis. Nineteen patients required late aortic valve reoperation and freedom from valve reoperation was 89.6% ± 2.9% at 10 years and was not significantly different between groups or between tricuspid or bicuspid valve phenotypes.
Our study shows that valve-sparing reimplantation is associated with low perioperative mortality, a remarkably low rate of valve-related complications, and excellent long-term durability. Further, it can be safely performed also in patients with isolated aortic regurgitation and the durability of valve repair is similar regardless of the indication for surgery of valve phenotype.
分析我们在应用保留瓣膜的再植入技术治疗孤立性根部动脉瘤、伴明显主动脉瓣反流的动脉瘤和孤立性主动脉瓣反流方面的长期经验。
在 1999 年至 2017 年间,我院对 440 例连续患者进行了保留瓣膜的再植入手术。该队列的平均年龄为 49±15 岁。采用 Kaplan-Meier 法进行时间事件分析,Cox 比例风险模型探索晚期结果的显著预测因素。
院内死亡率为 0.7%(n=3)。411 例患者可进行长期分析。中位随访时间为 5 年(四分位距,2-8.5 年)。36 例患者(8.5%)在随访期间死亡;因此,10 年时的生存率为 79.7%±3.8%。在随访期间,我们分别观察到 0.37%、0.73%和 0.2%的患者年出现重大出血、血栓栓塞事件和感染性心内膜炎的线性化率。19 例患者需要晚期主动脉瓣再次手术,10 年时无瓣膜再次手术的生存率为 89.6%±2.9%,各组之间或三尖瓣或二尖瓣表型之间无显著差异。
我们的研究表明,保留瓣膜的再植入与围手术期死亡率低、瓣膜相关并发症发生率极低以及长期耐久性极佳相关。此外,即使在孤立性主动脉瓣反流患者中,也可以安全地进行该手术,瓣膜修复的耐久性与手术指征和瓣膜表型无关。